Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2009

01-04-2009 | Original Article

HFE Gene Mutations, Serum Ferritin Level, Transferrin Saturation, and Their Clinical Correlates in a Korean Population

Authors: Sang Hyub Lee, Jin-Wook Kim, So Hyun Shin, Kyoung Phil Kang, Hyun Cheol Choi, Sung Hee Choi, Kyoung Un Park, Hyun Young Kim, Weechang Kang, Sook-Hyang Jeong

Published in: Digestive Diseases and Sciences | Issue 4/2009

Login to get access

Abstract

The aim of this study was to investigate HFE gene mutations, blood iron indices, and their clinical correlates in a Korean population. In 484 prospectively enrolled health-check examinees, HFE gene mutations and iron indices with clinical and laboratory variables were analyzed. Although neither the C282Y nor S65C gene mutation were found, the H63D heterozygote was detected in 41 subjects (8.5%). The mean serum ferritin and transferrin saturation (TS) were 136.2 ± 129.8 μg/dl and 39.2 ± 15.7%, respectively. The H63D genotype was not significantly associated with iron indices. High serum ferritin was associated with old age, the male gender, high body mass index (BMI), and the presence of nonalcoholic fatty liver disease (NAFLD). High TS was associated with the male gender and alcohol drinking. HFE gene mutation is rare; however, TS seems to be higher in Koreans compared to Caucasians or other ethnic groups. Serum ferritin reflects iron store as well as the presence of NAFLD.
Literature
3.
go back to reference Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS et al (1981) Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 304:319–324PubMed Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS et al (1981) Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 304:319–324PubMed
4.
go back to reference Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408. doi:10.1038/ng0896-399 PubMedCrossRef Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408. doi:10.​1038/​ng0896-399 PubMedCrossRef
5.
go back to reference Mura C, Raguenes O, Férec C (1999) HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502–2505PubMed Mura C, Raguenes O, Férec C (1999) HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502–2505PubMed
7.
go back to reference Beutler E, Felitti V, Gelbart T, Ho N (2000) The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 133:329–337PubMed Beutler E, Felitti V, Gelbart T, Ho N (2000) The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 133:329–337PubMed
9.
go back to reference Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778. doi:10.1056/NEJMoa041534 PubMedCrossRef Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778. doi:10.​1056/​NEJMoa041534 PubMedCrossRef
10.
go back to reference Koziol JA, Ho NJ, Felitti VJ, Beutler E (2001) Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 47:1804–1810PubMed Koziol JA, Ho NJ, Felitti VJ, Beutler E (2001) Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 47:1804–1810PubMed
11.
go back to reference Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278PubMedCrossRef Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278PubMedCrossRef
12.
15.
go back to reference Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J et al (2003) A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet 11:225–231. doi:10.1038/sj.ejhg.5200955 PubMedCrossRef Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J et al (2003) A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet 11:225–231. doi:10.​1038/​sj.​ejhg.​5200955 PubMedCrossRef
17.
go back to reference Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F et al (2001) Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48:836–842. doi:10.1136/gut.48.6.836 PubMedCrossRef Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F et al (2001) Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48:836–842. doi:10.​1136/​gut.​48.​6.​836 PubMedCrossRef
19.
20.
go back to reference Yenson PR, Yoshida EM, Li CH, Chung HV, Tsang PW (2008) Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience. Can J Gastroenterol 22:37–40PubMed Yenson PR, Yoshida EM, Li CH, Chung HV, Tsang PW (2008) Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience. Can J Gastroenterol 22:37–40PubMed
24.
go back to reference Porto G, Vicente C, Fraga J, da Silva BM, de Sousa M (1992) Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group. J Lab Clin Med 119:295–305PubMed Porto G, Vicente C, Fraga J, da Silva BM, de Sousa M (1992) Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group. J Lab Clin Med 119:295–305PubMed
25.
26.
go back to reference Bugianesi E, Manzini P, D’Antico S, Vanni E, Longo F, Leone N et al (2004) Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39:179–187. doi:10.1002/hep.20023 PubMedCrossRef Bugianesi E, Manzini P, D’Antico S, Vanni E, Longo F, Leone N et al (2004) Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39:179–187. doi:10.​1002/​hep.​20023 PubMedCrossRef
Metadata
Title
HFE Gene Mutations, Serum Ferritin Level, Transferrin Saturation, and Their Clinical Correlates in a Korean Population
Authors
Sang Hyub Lee
Jin-Wook Kim
So Hyun Shin
Kyoung Phil Kang
Hyun Cheol Choi
Sung Hee Choi
Kyoung Un Park
Hyun Young Kim
Weechang Kang
Sook-Hyang Jeong
Publication date
01-04-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0432-6

Other articles of this Issue 4/2009

Digestive Diseases and Sciences 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine